G 573

CAS No. 22868-35-5

G 573( G573 )

Catalog No. M13632 CAS No. 22868-35-5

G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM; blocks MEK phosphorylation by BRAF(V600E).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    G 573
  • Note
    Research use only, not for human use.
  • Brief Description
    G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM; blocks MEK phosphorylation by BRAF(V600E).
  • Description
    G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM; blocks MEK phosphorylation by BRAF(V600E), and stabilizes the RAF-MEK complex; inhibits the proliferation of A375 (BRAF V600E) with IC50 of 11 nM, 15-fold less potent for HCT116 (KRAS G13D).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    G573
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22868-35-5
  • Formula Weight
    228.68
  • Molecular Formula
    C13H9ClN2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC1=CC(C2=NC3=CC=CC=C3N2)=CC=C1
  • Chemical Name
    2-(3-Chlorophenyl)-1H-benzimidazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hatzivassiliou G, et al. Nature. 2013 Sep 12;501(7466):232-6.
molnova catalog
related products
  • Cobimetinib R-enanti...

    Cobimetinib R-enantiomer (GDC-0973; XL518) is the R-enantiomer of Cobimetinib (GDC-0973; XL518).

  • APS-2-79

    A small molecule compound that modulates KSR-dependent MAPK signalling by antagonizing RAF heterodimerization.

  • Selonsertib

    Selonsertib (GS-4997)?is a highly selective and potent, ATP-competetive inhibitor of ASK1 (Apoptosis Signal-regulating Kinase 1,?MAP3K5) with potential anti-inflammatory, antineoplastic and anti-fibrotic activities; orally bioavailable.